| The cost-effectiveness of physical activity in the management of COPD patients in the UK |
| Author(s): Ramos M1, Lamotte M1, Gerlier L1, Svangren P2, Miquel-Cases A3, Haughney J4 |
| Affiliations(s): 1 IQVIA, Zaventem, Belgium 2 Core Respiratory, Global Product and Portfolio Strategy - Global Payer Evidence and Pricing, AstraZeneca Gothenburg R&D, Mölndal, Sweden 3 Global Price and Reimbursement, Global Payer Evidence and Pricing, AstraZeneca Gothenburg R&D, Cambridge, UK 4 Academic Primary Care Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK. |
Publication(s): Int J Chron Obstruct Pulmon Dis. 2019 Jan 15;14:227-239
|
| Document Type(s): Article, |
| Countries: Scotland, |
| Click here for the abstract |
C:
Y: |
Health economics, Respiratory disease,
2019 |
|
L:
A: |
English
Cost effectiveness, |
|
 |
| |
| |
|
|
